0001836875
false
0001836875
2023-10-18
2023-10-18
0001836875
NVVE:CommonStockParValue0.0001PerShareMember
2023-10-18
2023-10-18
0001836875
NVVE:WarrantsToPurchaseCommonStockMember
2023-10-18
2023-10-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): October 18, 2023
NUVVE HOLDING CORP.
(Exact
Name of Registrant as Specified in Charter)
Delaware |
|
001-40296 |
|
86-1617000 |
(State
or Other Jurisdiction
of
Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification
No.) |
2488 Historic Decatur Road, San Diego, California |
|
92106 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: (619) 456-5161
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425). |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12). |
|
|
☐ |
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
|
|
☐ |
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
symbols |
|
Name
of each exchange on which registered |
Common Stock, Par Value $0.0001 Per Share |
|
NVVE |
|
The Nasdaq Stock Market LLC |
Warrants to Purchase Common Stock |
|
NVVEW |
|
The Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
8.01. Other Events.
On
October 18, 2023, Nuvve Holding Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”)
with Aegis Capital Corp., as the sole book-running manager and underwriter (the “Underwriter”), relating to an underwritten
public offering (the “Offering”) of 7,142,857 shares of common stock, par value $0.0001 per share (the “Common Stock”),
at a price to the public of $0.14 per share of Common Stock (the “Offering Price”). Pursuant to the Underwriting Agreement,
the Company granted the Underwriter a 45-day option to purchase up to 1,071,429 additional shares of Common Stock at the Offering Price,
less underwriting discounts and commissions (the “Over-Allotment Option”). On October 19, 2023, the Underwriter partially
exercised the Over-Allotment Option, electing to purchase an additional 797,243 shares of Common Stock.
The
Company expects to receive approximately $843,000 thousand in net proceeds from the Offering (including from the partial exercise of
the Over-Allotment Option), after deducting underwriting discounts and commissions and other estimated Offering expenses payable by the
Company, assuming no further exercise by the Underwriter of the Over-Allotment Option, or approximately $878,000 thousand if the Underwriter
exercises the remaining Over-Allotment Option in full. The shares of Common Stock are expected to be delivered to the Underwriter on
or about October 20, 2023, subject to the satisfaction of customary closing conditions.
The
Offering is being made pursuant to a shelf registration statement filed with and declared effective by the Securities and Exchange Commission
(the “SEC”) (Registration No. 333-264462), a base prospectus, dated May 5, 2022,
included as part of the registration statement, and a prospectus supplement, dated October 18, 2023.
The
Underwriting Agreement contains representations, warranties and covenants of the Company that are customary for transactions of this
type and customary conditions to closing. Additionally, the Company has agreed to provide
the Underwriter with customary indemnification rights under the Underwriting Agreement. The Company’s executive officers and directors
have also agreed, subject to certain exceptions, not to sell or transfer any securities
of the Company for a period of 60 days following the date of the final prospectus supplement without the approval of the Underwriter.
The
foregoing summary of the terms of the Underwriting Agreement is subject to, and qualified in its entirety by reference to, the copy of
the Underwriting Agreement that is filed as an exhibit to this Current Report on Form 8-K and are incorporated herein by reference. The
representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and,
as of specific dates, were solely for the benefit of the parties to the Underwriting Agreement, and may be subject to limitations agreed
upon by the contracting parties. Accordingly, the Underwriting Agreement is incorporated herein by reference only to provide investors
with information regarding the terms of the Underwriting Agreement, and not to provide investors with any other factual information regarding
the Company or its business, and should be read in conjunction with the disclosures in the Company’s periodic reports and other
filings with the SEC.
A
copy of the legal opinion and consent of Baker & Hostetler LLP relating to the shares of Common Stock is attached as Exhibit 5.1
hereto.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
October 20, 2023
|
NUVVE HOLDING CORP. |
|
|
|
|
By: |
/s/ Gregory
Poilasne |
|
|
Gregory Poilasne |
|
|
Chairman and Chief Executive Officer |
2
Exhibit 1.1
NUVVE HOLDING CORP.
UNDERWRITING
AGREEMENT
New York,
New York
October 18, 2023
Aegis Capital Corp.
1345 Avenue of the Americas, 27th Floor
New York, New
York 10015
Ladies and Gentlemen:
The undersigned,
Nuvve Holding Corp., a Delaware corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities
disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Nuvve Holding Corp.,
a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis
Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) as follows:
1. Purchase and Sale of Securities.
1.1 Firm Shares.
1.1.1 Nature and Purchase of Firm Shares.
(i) On
the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company
agrees to issue and sell to the Underwriter and the Underwriter agrees to purchase from the Company the aggregate number of securities
(the “Firm Securities”) set forth on Schedule 1 attached hereto and made a part hereof, consisting of shares (the “Firm
Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”) and pre-funded
warrants (the “Pre-funded Warrants”) in such quantities set forth on Schedule 2-A hereto. Each Pre-funded Warrant shall
entitle the holder to purchase one share of Common Stock at an exercise price of $0.001 per share until such time as the Pre-funded Warrants
are exercised in full, subject to adjustment as provided in the Pre-funded Warrant.
(ii) The
Firm Shares and Pre-funded Warrants are to be offered to the public at the offering price as set forth on the cover page of the Prospectus
(the “Public Purchase Price”). The purchase price for one Firm Share shall be $0.13 (or 93% of the Public Purchase
Price for one Firm Share) and the purchase for one Pre-funded Warrant shall be $0.129 (or 93% of the Public Purchase Price for one Firm
Share less 0.001).
1.1.2 Firm Shares Payment and Delivery.
(i) Delivery
and payment for the Firm Securities shall be made at 10:00 a.m., Eastern time, on the second (2nd) (or if the Firm Shares are
priced, as contemplated by Rule 15c6-1(c) under the Exchange Act, after 4:30 p.m., Eastern time, the third (3rd)) Business Day following
the date of this Agreement or at such earlier time as shall be agreed upon by the Underwriter and the Company, at the offices of Kaufman
& Canoles, P.C., Two James Center, 14th Floor, 1021 E. Cary St., Richmond, VA 23219 (“Underwriter’s Counsel”),
or at such other place (or remotely by facsimile or other electronic transmission) as shall be agreed upon by the Underwriter and the
Company. The hour and date of delivery and payment for the Firm Securities is called the “Closing Date.”
(ii) Payment
for the Firm Securities shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the
Company upon delivery of the certificates (in form and substance satisfactory to the Underwriter) representing the Firm Securities
or delivery through the facilities of the Depository Trust Company (“DTC”)) through its Deposit and Withdrawal at
Custodian system (“DWAC”) for the account of the Underwriter as provided to the Company in writing. The Firm
Securities shall be registered in such name or names and in such authorized denominations as the Underwriter may request in writing
at least two (2) full Business Days prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm
Securities except upon tender of payment by the Underwriter for all of the Firm Shares. The term “Business Day”
means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions are authorized or obligated
by law to close in New York, New York.
1.2 Over-allotment Option.
1.2.1 Option
Shares. For the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Securities, the
Company hereby grants to the Underwriter an option (the “Over- allotment Option”) to purchase additional shares of
the Common Stock and/or Pre-funded Warrants (the “Option Shares,” and along with the Firm Shares, the “Shares”)
as listed on Schedule 2-A, representing up to fifteen percent (15%) of the Firm Shares and Pre-funded Warrants sold in the offering; provided,
however, that in no event shall the aggregate value of the Shares and Pre-Funded Warrants sold in this offering exceed $2,150,000. The
purchase price to be paid per Option Share shall be equal to the price per Option Share set forth in Schedule 2-A. The Shares shall be
issued directly by the Company and shall have the rights and privileges described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus referred to below. The Shares, the Pre-funded Warrants and the shares of Common Stock underlying the Pre-funded
Warrants are hereinafter referred to together as the “Public Securities.” The offering and sale of the Shares is herein
referred to as the “Offering.”
1.2.2 Exercise
of Option. The Over-allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Underwriter as to all (at any
time) or any part (from time to time) of the Option Shares within forty-five (45) days after the Closing Date. The Underwriter shall not
be under any obligation to purchase any the Option Shares prior to the exercise of the Over-allotment Option. The Over-allotment Option
granted hereby may be exercised by the giving of written notice to the Company from the Underwriter, setting forth the number of the Option
Shares to be purchased and the date and time for delivery of and payment for the Option Shares (the “Option Closing Date”),
which shall not be later than five (5) full Business Days after the date of the notice or such other time as shall be agreed upon by the
Company and the Underwriter, at the offices of Underwriter’s Counsel or at such other place (including remotely by facsimile or
other electronic transmission) as shall be agreed upon by the Company and the Underwriter. If such delivery and payment for the Option
Shares does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment
Option with respect to all or any portion of the Option Shares subject to the terms and conditions set forth herein, (i) the Company shall
become obligated to sell to the Underwriter the number of the Option Shares specified in such notice.
1.2.3 Payment
and Delivery. Payment for the Option Shares shall be made on the Option Closing Date by wire transfer in Federal (same day) funds,
payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Underwriter) representing
the Option Shares or through DWAC for the account of the Underwriter. The Option Shares shall be registered in such name or names and
in such authorized denominations as the Underwriter may request in writing at least one (1) full Business Day prior to the Option Closing
Date. The Company shall not be obligated to sell or deliver the Option Shares except upon tender of payment by the Underwriter for applicable
Option Shares. The Option Closing Date may be simultaneous with, but not earlier than, the Closing Date; and in the event that such time
and date are simultaneous with the Closing Date, the term “Closing Date” shall refer to the time and date of delivery
of the Firm Securities and Option Shares.
2. Representations
and Warranties of the Company. The Company represents and warrants to the Underwriter as of the Applicable Time (as defined below),
as of the Closing Date and as of the Option Closing Date, if any, as follows:
2.1 Filing
of Registration Statement. The Company has filed with the U.S. Securities and Exchange Commission (the
“Commission”) a registration statement on Form S-3 (File No. 333-264462), including any related prospectus or
prospectuses, for the registration of certain securities of the Company, including the Securities, for sale from time to time under
the Securities Act of 1933, as amended (the “Securities Act”), which registration statement, including any
amendment or amendments thereto, was prepared by the Company in all material respects in conformity with the requirements of the
Securities Act and the rules and regulations of the Commission under the Securities Act (the “Securities Act
Regulations”) and contains and will contain all material statements that are required to be stated therein in accordance
with the Securities Act and the Securities Act Regulations. Except as the context may otherwise require, such registration statement
on file with the Commission at any given time, including any amendments thereto, financial statements, schedules, exhibits and all
other documents filed as a part thereof or incorporated therein and all information otherwise deemed to be a part thereof or
included therein pursuant to Rule 430B of the Securities Act Regulations (the “Rule 430B Information”) or
otherwise pursuant to the Securities Act Regulations is referred to herein as the “Registration Statement.” The
Registration Statement at the time it originally became effective is referred to herein as the “Initial Registration
Statement.” The Registration Statement was declared effective by the Commission on May 5, 2022.
The prospectus
in the form in which it was filed with the Commission in connection with the Initial Registration Statement is herein called the “Base
Prospectus.” Each preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus as so supplemented)
that described the Securities and the Offering and omitted the Rule 430B Information and that was used prior to the filing of the final
prospectus supplement referred to in the following paragraph is herein called a “Preliminary Prospectus.”
Promptly after
the execution and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement to the
Base Prospectus relating to the Securities and the Offering in accordance with the provisions of Rule 430B and Rule 424(b) of the Securities
Act Regulations. Such final prospectus supplement (including the Base Prospectus as so supplemented), in the form filed with the Commission
pursuant to Rule 424(b) under the Securities Act is herein called the “Prospectus.” Any reference herein to the Base
Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference
therein pursuant to Item 12 of Form S-3 under the Securities Act as of the date of such prospectus.
“Applicable Time” means 8:00 a.m., Eastern
time, on the date of this Agreement.
“Disclosure
Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Base Prospectus
as filed with the Commission on April 25, 2022, the Preliminary Prospectus and the information included on Schedule 2-A hereto, all considered
together.
“Issuer
Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 of the Securities Act
Regulations (“Rule 433”), including without limitation any “free writing prospectus” (as defined in Rule
405 of the Securities Act Regulations) relating to the Securities that is (i) required to be filed with the Commission by the Company,
(ii) a “road show that is a written communication” within the meaning of Rule 433(d)(8)(i), whether or not required to be
filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description
of the Securities or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with
the Commission or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g).
“Issuer
General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution to prospective
investors (other than a “bona fide electronic road show,” as defined in Rule 433 (the “Bona Fide Electronic
Road Show”)), as evidenced by its being specified in Schedule 2-B hereto.
“Issuer Limited Use Free Writing
Prospectus” means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.
2.2 Pursuant
to the Exchange Act. The Common Stock is registered pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). The Company has taken no action designed to, or likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating
terminating such registration.
2.3 Stock
Exchange Listing. The Common Stock is listed on the Nasdaq Capital Market (the “Exchange”), and the Company has
taken no action designed to, or likely to have the effect of, delisting the Common Stock from the Exchange, nor has the Company received
any notification that the Exchange is contemplating terminating such listing, except as described in the Registration Statement, the Disclosure
Package and the Prospectus.
2.4 No
Stop Orders, etc. Neither the Commission nor, to the Company’s knowledge, any state regulatory authority has issued any
order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
or, to the Company’s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has
complied with each request (if any) from the Commission for additional information with respect to the Registration Statement, any
Preliminary Prospectus or the Prospectus.
2.5 Disclosures in Registration Statement.
2.5.1 Compliance with Securities Act and 10b-5 Representation.
(i) Each of the Registration
Statement and any post-effective amendment thereto, at the time each part thereof became effective (including each deemed effective
date with respect to the Underwriter pursuant to Rule 430B or otherwise under the Securities Act), complied and will comply in all
material respects with the requirements of the Securities Act and the Securities Act Regulations. The Company was at the time of the
filing of the Registration Statement eligible to use Form S-3. Except for the late Form 8-K filed on April 24, 2023, the Company is
currently eligible to use Form S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate
market value of Securities being sold pursuant to this Offering and during the prior twelve (12) calendar months as set forth in
General Instruction I.B.6 of Form S-3. Each Preliminary Prospectus, including the prospectus filed as part of the Registration
Statement as originally filed or as part of any amendment or supplement thereto, and the Prospectus, at the time each was or will be
filed with the Commission, complied and will comply in all material respects with the requirements of the Securities Act and the
Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriter for use in connection with this Offering and
the Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to
EDGAR, except to the extent permitted by Regulation S-T.
(ii) Neither
the Registration Statement nor any amendment thereto, at the effective time of each part thereof pursuant to the Securities Act and the
Securities Act Regulations, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), contained, contains
or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
(iii) The
Disclosure Package, as of the Applicable Time, at the Closing Date or at any Option Closing Date (if any), did not, does not and will
not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus hereto does
not conflict with the information contained in the Registration Statement, any Preliminary Prospectus or the Prospectus, and each such
Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Preliminary Prospectus as of the Applicable
Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading; provided, however, that this representation
and warranty and the representation in Section 2.5.1(ii) above shall not apply to statements made or statements omitted in reliance upon
and in conformity with written information furnished to the Company with respect to the Underwriter expressly for use in the Registration
Statement, the Disclosure Package or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree
that such information provided by or on behalf of any Underwriter consists solely of the following disclosure contained in the “Underwriting”
section of the Prospectus: (a) the information set forth under the sub-captions “Discretionary Accounts,” “Electronic
Offer, Sale and Distribution of Shares”, “Other Relationships”, “Stabilization,” and “Passive Market
Making” and (b) the table showing the number of Securities to be purchased by the Underwriter (the “Underwriter’s
Information”).
(iv) Neither
the Prospectus nor any amendment or supplement thereto, as of its issue date, at the time of any filing with the Commission pursuant to
Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will include an untrue statement of a material fact
or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to
the Underwriter’s Information.
2.5.2 Disclosure
of Agreements. The agreements and documents described in the Registration Statement, the Disclosure Package and the Prospectus
conform in all material respects to the descriptions thereof contained therein and there are no agreements or other documents
required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Disclosure
Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so
described or filed. Each agreement or other instrument (however characterized or described) to which the Company or any of its
direct or indirect subsidiaries, including each entity disclosed or described in the Registration Statement, the Disclosure Package
and the Prospectus as being a subsidiary of the Company (each, a “Subsidiary” and, collectively, the
“Subsidiaries”) is a party or by which it is or may be bound or affected and (i) that is referred to in the
Registration Statement, the Disclosure Package and the Prospectus, or (ii) is material to the business of the Company, has been duly
authorized and validly executed by the Company or any Subsidiary, is in full force and effect in all material respects and is
enforceable against the Company or any Subsidiary, and, to the Company’s knowledge, the other parties thereto, in accordance
with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting
creditors’ rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the
federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable
relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be
brought. None of such agreements or instruments has been assigned by the Company or any Subsidiary, and neither the Company, any
Subsidiary nor, to the Company’s knowledge, any other party is in default thereunder and, to the Company’s knowledge, no
event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder, except for
any default or event which would not reasonably be expected to result in a Material Adverse Change. To the Company’s
knowledge, performance by the Company or any Subsidiary of the material provisions of such agreements or instruments will not result
in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental or regulatory agency,
body or court, domestic or foreign, having jurisdiction over the Company, any Subsidiary or any their its respective assets or
businesses (each, a “Governmental Entity”), including, without limitation, those relating to environmental laws
and regulations, except for any violation which would not reasonably be expected to result in a Material Adverse Change.
2.5.3 Prior
Securities Transactions. Since the date of the Company’s last annual report on Form 10-K, no securities of the Company have
been sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by or under common
control with the Company, except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, issuance of securities
upon exercise of previously disclosed outstanding securities of the Company or de minimus issuances of securities in amounts totaling
in the aggregate less than 1% of the issued and outstanding shares of common stock.
2.5.4 Regulations.
The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects of federal, state,
local and all foreign laws, rules and regulations relating to (a) the Offering and (b) the business of the Company as currently
conducted or contemplated are correct and complete in all material respects and, to the Company’s knowledge, no other such
laws, rules or regulations are required to be disclosed in the Registration Statement, the Disclosure Package and the Prospectus
which are not so disclosed.
2.5.5 No
Other Distribution of Offering Materials. The Company has not, directly or indirectly, distributed and will not distribute any offering
material in connection with the Offering other than any Preliminary Prospectus, the Disclosure Package, the Prospectus and other materials,
if any, permitted under the Securities Act and consistent with Section 3.2 below.
| 2.6 | Changes After Dates in Registration Statement. |
2.6.1 No
Material Adverse Change. Since the respective dates as of which information is given in the Registration Statement, the Disclosure
Package and the Prospectus, except as otherwise specifically stated or incorporated by reference therein: (i) there has been no material
adverse change in the financial position or results of operations of the Company and its Subsidiaries (taken as a whole), nor any change
or development that, singularly or in the aggregate, would involve a material adverse change or a prospective material adverse change,
in or affecting the condition (financial or otherwise), results of operations, business or assets of the Company and its Subsidiaries
(taken as a whole) (a “Material Adverse Change”); (ii) there have been no material transactions entered into by the
Company or any Subsidiary, other than as contemplated pursuant to this Agreement; and (iii) no officer or director of the Company has
resigned from any position with the Company.
2.6.2 Recent
Securities Transactions, etc. Subsequent to the respective dates as of which information is given in the Registration Statement, the
Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration
Statement, the Disclosure Package and the Prospectus, the Company has not: (i) issued any securities, other than securities issued pursuant
to the Company’s existing equity incentive or stock option plans or shares of Common Stock issuable upon the exercise of then outstanding
options, warrants and convertible securities or de minimus issuances of securities in amounts totaling in the aggregate less than
1% of the issued and outstanding shares of common stock, or incurred any liability or obligation, direct or contingent, for borrowed money;
or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock.
2.7 Disclosures
in Commission Filings. Since March 31, 2022, (i) none of the Company’s filings with the Commission contained any untrue statement
of a material fact or omitted to state any material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading; and (ii) the Company has made all filings with the Commission required under the Exchange
Act and the rules and regulations of the Commission promulgated thereunder (the “Exchange Act Regulations”).
2.8 Independent
Accountants. To the knowledge of the Company, Deloitte & Touche LLP for the year ended December 31, 2022, and Moss Adams LLP for
the year ended December 31, 2021 (collectively, the “Auditor”), whose reports are filed with the Commission and incorporated
in the Registration Statement, the Disclosure Package and the Prospectus, are independent registered public accounting firms as required
by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. The Auditor has not, during
the periods covered by the financial statements included in the Registration Statement, the Disclosure Package and the Prospectus, provided
to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.
2.9 Financial
Statements, etc. The financial statements, including the notes thereto and supporting schedules included or incorporated by
reference in the Registration Statement, the Disclosure Package and the Prospectus, fairly present the financial position and the
results of operations of the Company at the dates and for the periods to which they apply; and such financial statements have been
prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), consistently applied
throughout the periods involved (provided that unaudited interim financial statements are subject to year-end audit adjustments that
are not expected to be material in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules
included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus present fairly the
information required to be stated therein. Except as included or incorporated by reference therein, no historical or pro forma
financial statements are required to be included or incorporated by reference in the Registration Statement, the Disclosure Package
or the Prospectus under the Securities Act or the Securities Act Regulations. The pro forma and pro forma as adjusted financial
information and the related notes, if any, included or incorporated by reference in the Registration Statement, the Disclosure
Package and the Prospectus have been properly compiled and prepared in accordance with the applicable requirements of the Securities
Act and the Securities Act Regulations and present fairly the information shown therein, and the assumptions used in the preparation
thereof are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances
referred to therein. All disclosures contained or incorporated by reference in the Registration Statement, the Disclosure Package or
the Prospectus regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the
Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent
applicable. Each of the Registration Statement, the Disclosure Package and the Prospectus discloses all material off-balance sheet
transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company with
unconsolidated entities or other persons that may have a material current or future effect on the Company’s financial
condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant
components of revenues or expenses. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus,
(a) neither the Company nor any of its Subsidiaries, including each entity disclosed or described in the Registration Statement, the
Disclosure Package and the Prospectus as being a Subsidiary of the Company, has incurred any material liabilities or obligations,
direct or contingent, or entered into any material transactions other than in the ordinary course of business, (b) neither the
Company nor any of its Subsidiaries has declared or paid any dividends or made any distribution of any kind with respect to its
capital stock, (c) there has not been any change in the capital stock of the Company or any of its Subsidiaries, (d) other than in
the ordinary course of business and consistent with the Company’s prior policies, the Company has not made any grants under
any stock compensation plan, and (e) there has not been any material adverse change in the long-term or short- term debt of the
Company or any of its Subsidiaries.
2.10 Authorized
Capital; Options, etc. The Company had, at the date or dates indicated in the Registration Statement, the Disclosure Package and the
Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions stated in the Registration
Statement, the Disclosure Package and the Prospectus, the Company will have on the Closing Date the adjusted stock capitalization set
forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Disclosure Package and the Prospectus, as of
the Applicable Time and on the Closing Date and any Option Closing Date, there will be no stock options, warrants, or other rights to
purchase or otherwise acquire any authorized but unissued shares of Common Stock of the Company or equity securities of any Subsidiary
or any security convertible or exercisable into shares of Common Stock of the Company or equity securities of any Subsidiary, or any contracts
or commitments to issue or sell shares of Common Stock of the Company or equity securities of any Subsidiary or any such options, warrants,
rights or convertible securities.
2.11 Valid Issuance of Securities, etc.
2.11.1 Outstanding
Securities. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have
been duly authorized and validly issued and are fully paid and non-assessable; except as set forth in the Registration Statement, the
Disclosure Package and the Prospectus, the holders thereof have no rights of rescission or the ability to force the Company to repurchase
such securities with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities
were issued in violation of the preemptive rights, rights of first refusal or rights of participation of any holders of any security of
the Company or similar contractual rights granted by the Company. The authorized shares of Common Stock conform in all material respects
to all statements relating thereto contained in the Registration Statement, the Disclosure Package and the Prospectus. Except such as
would not reasonably be expected to result in a Material Adverse Change, the offers and sales of the outstanding shares of Common Stock,
options, warrants and other rights to purchase or exchange such securities for shares of Common Stock were at all relevant times either
registered under the Securities Act and the applicable state securities or “blue sky” laws or, based in part on the representations
and warranties of the purchasers of such securities, exempt from such registration requirements. The description of the Company’s
stock option, stock bonus and other stock plans or arrangements, and the options or other rights granted thereunder, as described in the
Registration Statement, Disclosure Package and the Prospectus, accurately and fairly present, in all material respects, the information
required to be shown with respect to such plans, arrangements, options and rights.
2.11.2 Securities
Sold Pursuant to this Agreement. The Public Securities have been duly authorized for issuance and sale and, when issued and paid for,
will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability by reason
of being such holders; the Public Securities are not and will not be subject to the preemptive rights of any holders of any security of
the Company or similar contractual rights granted by the Company; and all corporate action required to be taken for the authorization,
issuance and sale of the Public Securities has been duly and validly taken; the Common Stock issuable upon exercise of the Pre-funded
Warrants has been duly authorized and reserved for issuance by all necessary corporate action on the part of the Company and when issued
in accordance with the Pre-funded Warrants and the warrant agent agreement (the “Warrant Agent Agreement”), as the case may
be, such Common Stock will be validly issued, fully paid and non- assessable. The Shares and the Pre-funded Warrants conform in all material
respects to all statements with respect thereto contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.
2.12 Registration
Rights of Third Parties. Except as set forth in the Registration Statement, the Disclosure Package and the Prospectus, no holders
of any securities of the Company or any options, warrants, rights or other securities exercisable for or convertible or exchangeable into
securities of the Company have the right to require the Company to register any such securities of the Company under the Securities Act
or to include any such securities in the Registration Statement or any other registration statement to be filed by the Company.
2.13 Validity
and Binding Effect of Agreements. This Agreement, the Pre-funded Warrants and the Warrant Agent Agreement have been duly and
validly authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreements of the
Company, enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability may be
limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally; (ii) as
enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; and
(iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefor may be brought.
2.14 No
Conflicts, etc. The execution, delivery and performance by the Company of this Agreement, the Pre-funded Warrants and the Warrant
Agent Agreement and all ancillary documents, the consummation by the Company of the transactions herein contemplated and the compliance
by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both:
(i) result in a breach of, or conflict with any of the terms and provisions of, or constitute a material default under, or result in the
creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any
of its Subsidiaries pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement or any other agreement or instrument
to which the Company or any of its Subsidiaries is a party or as to which any property of the Company or any of its Subsidiaries is bound;
(ii) result in any violation of the provisions of the Company’s Certificate of Incorporation (as the same have been amended or restated
from time to time, the “Charter”), the Company’s By-Laws (as the same have been amended or restated from time
to time, the “Bylaws”), the certificate of incorporation of any Subsidiary or the bylaws of any Subsidiary (as applicable);
or (iii) violate any existing applicable law, rule, regulation, judgment, order or decree of any Governmental Entity as of the date hereof,
except in the cases of clauses (i) and (iii) for such breaches, conflicts or violations which would not reasonably be expected to have
a Material Adverse Change.
2.15 No
Defaults; Violations; Customers and Suppliers. No material default exists in the due performance and observance of any term, covenant
or condition of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement
or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company or any of
its Subsidiaries is a party or by which the Company or any of its Subsidiaries may be bound or to which any of the properties or assets
of the Company or any of its Subsidiaries is subject. Neither the Company nor any of its Subsidiaries is (i) in violation of any term
or provision of its charter or bylaws, or (ii) in violation of any franchise, license, permit, applicable law, rule, regulation, judgment
or decree of any Governmental Entity, except in the cases of clause (ii) for such violations which would not reasonably be expected to
result in a Material Adverse Change. No supplier, customer, distributor or sales agent of the Company or any Subsidiary has notified the
Company or any Subsidiary that it intends to discontinue or decrease the rate of business done with the Company or any Subsidiary, except
where such discontinuation or decrease has not resulted in and could not reasonably be expected to result in a Material Adverse Change.
2.16 Corporate Power; Licenses; Consents.
2.16.1 Conduct
of Business. Except as described in the Registration Statement, the Disclosure Package and the Prospectus and such as could not reasonably
be expected to result in a Material Adverse Change, each of the Company and its Subsidiaries has all requisite corporate power and authority,
and has all necessary consents, authorizations, approvals, orders, licenses, certificates, qualifications, registrations and permits (collectively,
the “Authorizations”) of and from all Governmental Entities that it needs as of the date hereof to conduct its respective
business as described in the Registration Statement, the Disclosure Package and the Prospectus.
2.16.2 Transactions
Contemplated Herein. The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions
and conditions hereof, and all Authorizations required in connection therewith have been obtained. Except for the filing of an Additional
Listing Notification with the Exchange with respect to the sale of the Securities, no Authorization of, and no filing with, any court
or Governmental Entity is required for the valid issuance, sale and delivery of the Securities and the consummation of the transactions
and agreements contemplated by this Agreement and as contemplated by the Registration Statement, the Disclosure Package and the Prospectus,
except with respect to applicable federal and state securities laws and the rules and regulations of the Financial Industry Regulatory
Authority, Inc. (“FINRA”).
2.17 D&O
Questionnaires. To the Company’s knowledge, all information contained in the questionnaires (the
“Questionnaires”) provided by the Underwriter and completed by each of the Company’s directors and officers
immediately prior to the Offering (the “Insiders”) as supplemented by all information concerning the
Company’s directors and officers as described in the Registration Statement, the Disclosure Package and the Prospectus,
provided to the Underwriter is true and correct in all material respects and the Company has not become aware of any information
which would cause the information disclosed in the Questionnaires to become inaccurate and incorrect in any material respect.
2.18 Litigation;
Governmental Proceedings. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental
proceeding pending or, to the Company’s knowledge, threatened against, or adversely involving the Company, any of its Subsidiaries
or, to the Company’s knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the
Disclosure Package and the Prospectus which is required to be disclosed.
2.19 Good
Standing. Each of the Company and its Subsidiaries has been duly organized and is validly existing as a corporation or limited liability
company, as applicable, and is in good standing under the laws of its jurisdiction of incorporation or formation as of the date hereof,
and is duly qualified to do business and is in good standing in each other jurisdiction in which its ownership or lease of property or
the conduct of business requires such qualification, except where the failure to qualify, singularly or in the aggregate, would not have
or reasonably be expected to result in a Material Adverse Change.
2.20 Insurance.
The Company and each of its Subsidiaries carries or is entitled to the benefits of insurance (including, without limitation, as to directors
and officers insurance coverage), with reputable insurers, in such amounts and covering such risks which the Company believes are adequate,
and all such insurance is in full force and effect. The Company has no reason to believe that it or any of its Subsidiaries will not be
able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar
institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material
Adverse Change.
2.21 Transactions Affecting Disclosure to FINRA.
2.21.1 Finder’s
Fees. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, there are no claims, payments,
arrangements, agreements or understandings relating to the payment of a finder’s, consulting or origination fee by the Company or
any Insider with respect to the sale of the Securities hereunder or any other arrangements, agreements or understandings of the Company
or, to the Company’s knowledge, any of its shareholders that may affect the Underwriter’s compensation, as determined by FINRA.
Other than the Underwriter, no person has the right to act as an underwriter or as a financial advisor to the Company in connection with
the transactions contemplated hereby.
2.21.2 Payments
Within Six (6) Months. Except as described in the Registration Statement, the Disclosure Package and the Prospectus or in connection
with the ATM Facility (as defined herein), the Company has not made any direct or indirect payments (in cash, securities or otherwise)
to: (i) any person, as a finder’s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company
or introducing to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity
that has any direct or indirect affiliation or association with any FINRA member, within the six (6) months prior to the initial filing
of the Registration Statement, other than the payment to the Underwriter as provided hereunder in connection with the Offering.
2.21.3 Use
of Proceeds. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates,
except as specifically authorized herein.
2.21.4 FINRA
Affiliation. There is no (i) officer or director of the Company, (ii) to the Company’s knowledge, any beneficial owner of 5%
or more of any class of the Company’s securities or (iii) to the Company’s knowledge, any beneficial owner of the Company’s
unregistered equity securities which were acquired during the 180-day period immediately preceding the filing of the Registration Statement
that is an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules
and regulations of FINRA).
2.21.5 Information.
All information provided by the Company in its FINRA questionnaire to Underwriter’s Counsel specifically for use by Underwriter’s
Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all
material respects.
2.22 Foreign
Corrupt Practices Act. Neither the Company or any of its Subsidiaries nor, to the Company’s knowledge, any director, officer,
agent, employee or affiliate of the Company or any of its Subsidiaries nor, to the Company’s knowledge, any other person acting
on behalf of the Company or any of its Subsidiaries, has, directly or indirectly, given or agreed to give any money, gift or similar benefit
(other than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee or agent of a
customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or
any political party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder
the business of the Company or any of its Subsidiaries (or assist it in connection with any actual or proposed transaction) that (i) might
subject the Company or any of its Subsidiaries to any material damage or penalty in any civil, criminal or governmental litigation or
proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future, might adversely
affect the assets, business, operations or prospects of the Company or any of its Subsidiaries. The Company and each of its Subsidiaries
has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all
material respects with the Foreign Corrupt Practices Act of 1977, as amended.
2.23 Compliance
with OFAC. Neither the Company or any of its Subsidiaries nor, to the Company’s knowledge, any director, officer, agent, employee
or affiliate of the Company or any of its Subsidiaries nor, to the Company’s knowledge, any other person acting on behalf of the
Company or any of its Subsidiaries, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of
the U.S. Department of the Treasury (“OFAC”), and the Company will not, directly or indirectly, use the proceeds of
the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other
person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.
2.24 Money
Laundering Laws. The operations of the Company and each of its Subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money Laundering Laws”);
and no action, suit or proceeding by or before any Governmental Entity involving the Company or any of its Subsidiaries with respect to
the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.
2.25 Forward-Looking
Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) contained in either the Registration Statement, Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable
basis or has been disclosed other than in good faith.
2.26 Officers’
Certificate. Any certificate signed by any duly authorized officer of the Company and delivered to you or to Underwriter’s Counsel
shall be deemed a representation and warranty by the Company to the Underwriter as to the matters covered thereby.
2.27 Lock-Up
Agreements. Schedule 3 hereto contains a complete and accurate list of the Company’s executive officers and directors
(collectively, the “Lock-Up Parties”). The Company has caused each of the Lock-Up Parties to deliver to the Underwriter
an executed Lock-Up Agreement, substantially in a form and substance reasonably satisfactory to the Underwriter (the “Lock-Up
Agreement”), prior to the execution of this Agreement, which shall provide for a lock-up period of sixty (60) days from the
Closing Date.
2.28 Subsidiaries.
All direct and indirect Subsidiaries of the Company are duly organized and in good standing under the laws of the place of
organization or incorporation, and each Subsidiary is in good standing in each jurisdiction in which its ownership or lease of
property or the conduct of business requires such qualification, except where the failure to qualify would not have a Material
Adverse Change. The Company’s ownership and control of each Subsidiary is as described in the Registration Statement, the
Disclosure Package and the Prospectus. No Subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying
any dividends to the Company, from making any other distributions on such Subsidiary’s capital stock, from repaying to the
Company any loans or advances to such Subsidiary from the Company or from transferring any of such Subsidiary’s property or
assets to the Company or any other Subsidiary of the Company, except as set forth or contemplated in the Registration Statement, the
Disclosure Package and the Prospectus. As of the date of this Agreement, the Company’s sole Subsidiaries are listed in Exhibit
21.1 to the Company’s most recent 10-K.
2.29 Related Party Transactions.
2.29.1 Business
Relationships. There are no business relationships or related party transactions involving the Company or any other person required
to be described in the Registration Statement, the Disclosure Package and the Prospectus that have not been described as required.
2.29.2 No
Relationships with Customers and Suppliers. No relationship, direct or indirect, exists between or among the Company on the one hand,
and the directors, officers, 5% or greater stockholders, customers or suppliers of the Company or any of the Company’s affiliates
on the other hand, which is required to be described in the Disclosure Package and the Prospectus or a document incorporated by reference
therein and which is not so described.
2.29.3 No
Unconsolidated Entities. There are no transactions, arrangements or other relationships between and/or among the Company, any of its
affiliates (as such term is defined in Rule 405 of the Securities Act) and any unconsolidated entity, including, but not limited to, any
structure finance, special purpose or limited purpose entity that could reasonably be expected to have a material adverse effect on the
Company’s liquidity or the availability of or requirements for its capital resources required to be described in the Disclosure
Package and the Prospectus or a document incorporated by reference therein which have not been described as required.
2.29.4 No
Loans or Advances to Affiliates. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary
course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of the Company
or any of their respective family members, except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus.
2.30 Board
of Directors. The qualifications of the persons serving as members of the Company’s Board of Directors and the overall composition
of the Board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
(the “Sarbanes-Oxley Act”) applicable to the Company and the listing rules of the Exchange. At least one member of
the Audit Committee of the Board of Directors of the Company qualifies as an “audit committee financial expert,” as such term
is defined under Regulation S-K and the listing rules of the Exchange. In addition, at least a majority of the persons serving on the
Board of Directors qualify as “independent,” as defined under the listing rules of the Exchange.
2.31 Sarbanes-Oxley Compliance.
2.31.1 Disclosure
Controls. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company has developed
and currently maintains disclosure controls and procedures that comply with Rule 13a-15 or 15d-15 under the Exchange Act Regulations,
and such controls and procedures are effective to the extent or except as otherwise disclosed in the Registration Statement, the Disclosure
Package and the Prospectus to ensure that all material information concerning the Company will be made known on a timely basis to the
individuals responsible for the preparation of the Company’s Exchange Act filings and other public disclosure documents.
2.31.2 Compliance.
The Company is, or at the Applicable Time and on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley
Act applicable to it, and has implemented or will implement such programs and taken reasonable steps to ensure the Company’s future
compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the material provisions of the Sarbanes-Oxley
Act applicable to it.
2.32 Accounting
Controls. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company and each of its
Subsidiaries maintains systems of “internal control over financial reporting” (as defined under Rules 13a-15 and 15d-15 under
the Exchange Act Regulations) that comply in all material respects with the requirements of the Exchange Act and have been designed by,
or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access
to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company is not aware of any material
weaknesses in its internal controls. The Company’s auditors and the Audit Committee of the Board of Directors of the Company have
been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial
reporting which are known to the Company’s management and that have adversely affected or are reasonably likely to adversely affect
the Company’ ability to record, process, summarize and report financial information; and (ii) any fraud known to the Company’s
management, whether or not material, that involves management or other employees who have a significant role in the Company’s internal
controls over financial reporting.
2.33 No
Investment Company Status. The Company is not and, after giving effect to the Offering and the application of the proceeds thereof
as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be, required to register as an “investment
company,” as defined in the Investment Company Act of 1940, as amended.
2.34 No
Labor Disputes. There is (A) no unfair labor practice complaint pending against the Company, or any of its subsidiaries, nor to the
Company’s knowledge, threatened against it or any of its subsidiaries, before the National Labor Relations Board, any state or local
labor relation board or any foreign labor relations board, and no grievance or arbitration proceeding arising out of or under any collective
bargaining agreement is so pending against the Company or any of its Subsidiaries, or, to the Company’s knowledge, threatened against
it and (B) no labor disturbance by the employees of the Company or any of its subsidiaries exists or, to the Company’s knowledge,
is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its subsidiaries,
principal suppliers, manufacturers, customers or contractors, that could reasonably be expected, singularly or in the aggregate, to constitute
a Material Adverse Change. The Company is not aware that any key employee or significant group of employees of the Company plans to terminate
employment with the Company.
2.35 Intellectual
Property Rights. The Company and each of its Subsidiaries owns or possesses or has valid rights to use all patents, patent
applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses,
inventions, trade secrets, software, databases, know-how, internet domain names, other unpatented and/or un-patentable proprietary
confidential information systems, processes or procedures and similar rights (“Intellectual Property Rights”)
necessary for the conduct of the business of the Company or its Subsidiaries as currently carried on and as described in the
Registration Statement, the Disclosure Package and the Prospectus. To the knowledge of the Company, no action or use by the Company
or any of its Subsidiaries necessary for the conduct of their respective businesses as currently carried on and as described in the
Registration Statement and the Prospectus will involve or give rise to any infringement of, or license or similar fees for, any
Intellectual Property Rights of others. Neither the Company nor any of its Subsidiaries has received any written notice alleging any
such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as would not reasonably be expected
to result, individually or in the aggregate, in a Material Adverse Change or as otherwise as disclosed in the Registration
Statement, the Disclosure Package and the Prospectus, (A) to the knowledge of the Company, there is no infringement,
misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company or any of its
Subsidiaries; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, governmental review, proceeding
or claim by others challenging the rights of the Company or any of its Subsidiaries in or to any such Intellectual Property Rights,
and the Company is unaware of any facts which would form a reasonable basis for any such claim, that would, individually or in the
aggregate, together with any other claims in this Section 2.35, reasonably be expected to result in a Material Adverse Change; (C)
the Intellectual Property Rights owned by the Company or any of its Subsidiaries and, to the knowledge of the Company, the
Intellectual Property Rights licensed to the Company or any of its Subsidiaries have not been adjudged by a court of competent
jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or, to the Company’s knowledge, threatened
action, suit, governmental review, proceeding or claim by others challenging the validity or scope of any such Intellectual Property
Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim that would, individually or
in the aggregate, together with any other claims in this Section 2.35, reasonably be expected to result in a Material Adverse
Change; (D) there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others that
the Company or any of its Subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property Rights or other
proprietary rights of others, neither the Company nor any of its Subsidiaries has received any written notice of such claim and the
Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or in the
aggregate, together with any other claims in this Section 2.35, reasonably be expected to result in a Material Adverse Change; and
(E) to the Company’s knowledge, no employee of the Company or any of its Subsidiaries is in or has ever been in violation in
any material respect of any term of any employment contract, patent disclosure agreement, invention assignment agreement,
non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former
employer where the basis of such violation relates to such employee’s employment with the Company or any of its Subsidiaries,
or actions undertaken by the employee while employed with the Company or any of its Subsidiaries and could reasonably be expected to
result, individually or in the aggregate, in a Material Adverse Change. To the Company’s knowledge, all material technical
information developed by and belonging to the Company or any of its Subsidiaries which has not been patented has been kept
confidential. Neither the Company nor any of its Subsidiaries is a party to or bound by any options, licenses or agreements with
respect to the Intellectual Property Rights owned by any other person or entity that are required to be set forth in the
Registration Statement, the Disclosure Package and the Prospectus and are not described therein. The Registration Statement, the
Disclosure Package and the Prospectus contain in all material respects the same description of the matters set forth in the
preceding sentence. None of the technology employed by the Company or any of its Subsidiaries has been obtained or is being used by
the Company or any of its Subsidiaries in violation of any contractual obligation binding on the Company or any of its Subsidiaries
or, to the Company’s knowledge, any of its officers, directors or employees, or otherwise in violation of the rights of any
persons.
2.36 Taxes.
Except for matters that would not individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Change,
each of the Company and its Subsidiaries has (i) filed all returns (as hereinafter defined) required to be filed with taxing authorities
prior to the date hereof or has duly obtained extensions of time for the filing thereof, and (ii) paid all taxes (as hereinafter defined)
shown as due on such returns that were filed and has paid all taxes imposed on or assessed against the Company or such respective Subsidiary.
The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient
for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial
statements. Except as disclosed in writing to the Underwriter, (i) no issues have been raised (and are currently pending) by any taxing
authority in connection with any of the returns or taxes asserted as due from the Company or its Subsidiaries, and (ii) no waivers of
statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company or its Subsidiaries.
The term “taxes” mean all federal, state, local, foreign and other net income, gross income, gross receipts, sales,
use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance,
stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges of any kind whatever,
together with any interest and any penalties, additions to tax or additional amounts with respect thereto. The term “returns”
means all returns, declarations, reports, statements and other documents required to be filed in respect to taxes
2.37 Compliance
with Environmental Laws. Except for matters that would not individually or in the aggregate, have or reasonably be expected to
result in a Material Adverse Change or as otherwise described in the Registration Statement, the Disclosure Package and the
Prospectus, (i) neither the Company nor any of its Subsidiaries is in material violation of any federal, state, local or foreign
statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation
thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human
health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata)
or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals,
pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively,
“Hazardous Materials”) or to the manufacture, processing, distribution, use, treatment, storage, disposal,
transport or handling of Hazardous Materials (collectively, “Environmental Laws ), (ii) the Company and each of its
Subsidiaries has all material permits, authorizations and approvals required under any applicable Environmental Laws and is in
compliance with their requirements, (iii) there are no pending or, to the Company’s knowledge, threatened administrative,
regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation
or proceedings relating to any Environmental Law against the Company or any of its Subsidiaries and (iv) to the Company’s
knowledge, there are no events or circumstances that might reasonably be expected to form the basis of an order for clean-up or
remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company
or any of its Subsidiaries relating to Hazardous Materials or any Environmental Laws.
2.38 ERISA
Compliance. The Company and any “employee benefit plan” (as defined under the Employee Retirement Income Security Act
of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”)) established
or maintained by the Company or its “ERISA Affiliates” (as defined below) are in compliance in all material respects with
ERISA. “ERISA Affiliate” means, with respect to the Company, any member of any group of organizations described in
Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder
(the “Code”) of which the Company is a member. No “reportable event” (as defined under ERISA) has occurred
or is reasonably expected to occur with respect to any “employee benefit plan” established or maintained by the Company or
any of its ERISA Affiliates. No “employee benefit plan” established or maintained by the Company or any of its ERISA Affiliates,
if such “employee benefit plan” were terminated, would have any “amount of unfunded benefit liabilities” (as defined
under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material liability under
(i) Title IV of ERISA with respect to termination of, or withdrawal from, any “employee benefit plan” or (ii) Sections 412,
4971, 4975 or 4980B of the Code. Each “employee benefit plan” established or maintained by the Company or any of its ERISA
Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge of the Company, nothing
has occurred, whether by action or failure to act, which would cause the loss of such qualification. The execution of this Agreement,
or consummation of the Offering does not constitute a triggering event under any employee benefit plan or any other employment contract,
whether or not legally enforceable, which (either alone or upon the occurrence of any additional or subsequent event) will or may result
in any payment (of severance pay or otherwise), acceleration, increase in vesting, or increase in benefits to any current or former participant,
employee or director of the Company other than an event that is not material to the financial condition or business of the Company.
2.39 Compliance
with Laws. Except for matters that would not individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Change or as otherwise described in the Registration Statement, the Disclosure Package and the Prospectus, the Company and each
of its Subsidiaries: (A) is and at all times has been in compliance with all statutes, rules, or regulations applicable to the ownership,
testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage,
import, export or disposal of any product manufactured or distributed by the Company (“Applicable Laws”); (B) possesses
all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term
of any such Authorizations; (C) except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, has not
received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental
Entity or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations and has
no knowledge that any such governmental authority or third party is considering any such claim, litigation, arbitration, action, suit,
investigation or proceeding; (D) has not received notice that any Governmental Entity has taken, is taking or intends to take action to
limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority is considering such action;
and (E) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions
and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments were complete and materially correct on the date filed (or were
corrected or supplemented by a subsequent submission).
2.40 Smaller
Reporting Company. As of the time of filing of the Registration Statement and as of its effective time, the Company was a “smaller
reporting company,” as defined in Rule 12b-2 of the Exchange Act Regulations.
2.41 Industry
Data. The statistical and market-related data included in each of the Registration Statement, the Disclosure Package and the Prospectus
are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the
Company’s good faith estimates that are made on the basis of data derived from such sources, and the Company has obtained the written
consent to use such data from such sources, to the extent required.
2.42 Margin
Securities. The Company does not own any “margin securities” as that term is defined in Regulation U of the Board of Governors
of the Federal Reserve System (the “Federal Reserve Board”), and none of the proceeds of Offering will be used, directly
or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness
which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of
Common Stock to be considered a “purpose credit” within the meanings of Regulation T, U or X of the Federal Reserve Board.
2.43 Integration.
Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering to be integrated
with prior offerings by the Company for purposes of the Securities Act that would require the registration of any such securities under
the Securities Act.
2.44 Title.
Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company and each of its Subsidiaries
has good and marketable title in fee simple to, or has valid rights to lease or otherwise use, all items of real or personal property
that are material to its respective business, free and clear of all liens, encumbrances, security interests, claims and defects that do
not, singularly or in the aggregate, result in a Material Adverse Change and do not interfere with the use made of such property by the
Company or its Subsidiaries; and all of the leases and subleases material to the business of the Company and each of its Subsidiaries,
and under which the Company or any of its Subsidiaries holds properties described in the Registration Statement, the Disclosure Package
and the Prospectus, are, to the Company’s knowledge in full force and effect, and neither the Company nor any of its Subsidiaries
has received any notice of any material claim of any sort that have been asserted by anyone adverse to the rights of the Company or such
Subsidiaries under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such Subsidiaries
to the continued possession of the leased or subleased premises under any such lease or sublease, which would result in a Material Adverse
Change.
2.45 Confidentiality
and Non-Competition. To the Company’s knowledge, no director, officer, key employee or consultant of the Company is subject
to any confidentiality, non-disclosure, non-competition or non- solicitation agreement with any employer or prior employer that could
materially affect his or her ability to be and act in his or her respective capacity with the Company or be expected to result in a Material
Adverse Change.
| 3. | Covenants of the Company. The Company covenants and agrees as follows: |
3.1 Amendments
to Registration Statement. The Company shall deliver to the Underwriter, prior to filing, any amendment or supplement to the Registration
Statement, any Preliminary Prospectus, the Disclosure Package or the Prospectus proposed to be filed and shall not file any such amendment
or supplement to which the Underwriter shall reasonably object in writing.
3.2 Federal Securities Laws.
3.2.1 Compliance.
The Company, subject to Section 3.2.2, shall comply with the requirements of Rule 424(b) and Rule 430B of the Securities Act
Regulations, and will notify the Underwriter promptly, and confirm the notice in writing, (i) when any post-effective amendment to
the Registration Statement or any amendment or supplement to any Preliminary Prospectus, the Disclosure Package or the Prospectus
shall have been filed and when any post-effective amendment to the Registration Statement shall become effective; (ii) of the
receipt of any comments from the Commission; (iii) of any request by the Commission for any amendment to the Registration Statement
or any amendment or supplement to any Preliminary Prospectus, the Disclosure Package or the Prospectus or for additional
information; (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or
any post-effective amendment or of any order preventing or suspending the use of any Preliminary Prospectus, the Disclosure Package
or the Prospectus, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the
initiation or threatening of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of the
Securities Act concerning the Registration Statement; and (v) if the Company becomes the subject of a proceeding under Section 8A of
the Securities Act in connection with the Offering of the Securities. The Company shall effect all filings required under Rule
424(b) of the Securities Act Regulations, in the manner and within the time period required by Rule 424(b) (without reliance on Rule
424(b)(8)), and shall take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted for
filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such
prospectus. The Company shall use its best efforts to prevent the issuance of any stop order, prevention or suspension and, if any
such order is issued, to obtain the lifting thereof at the earliest possible moment.
3.2.2 Continued
Compliance. The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the Exchange Act
Regulations so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and in the Registration
Statement, the Disclosure Package and the Prospectus. If at any time when a prospectus relating to the Securities is (or, but for the
exception afforded by Rule 172 of the Securities Act Regulations (“Rule 172”), would be) required by the Securities
Act to be delivered in connection with sales of the Securities, any event shall occur or condition shall exist as a result of which it
is necessary, in the opinion of counsel for the Underwriter or for the Company, to (i) amend the Registration Statement in order that
the Registration Statement will not include an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; (ii) amend or supplement the Disclosure Package or the Prospectus
in order that the Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein not misleading in light of the circumstances existing
at the time it is delivered to a purchaser; or (iii) amend the Registration Statement or amend or supplement the Disclosure Package or
the Prospectus, as the case may be, in order to comply with the requirements of the Securities Act or the Securities Act Regulations,
the Company will promptly (A) give the Underwriter notice of such event; (B) prepare any amendment or supplement as may be necessary to
correct such statement or omission or to make the Registration Statement, the Disclosure Package or the Prospectus comply with such requirements
and, a reasonable amount of time prior to any proposed filing or use, furnish the Underwriter with copies of any such amendment or supplement
and (C) file with the Commission any such amendment or supplement; provided that the Company shall not file or use any such amendment
or supplement to which the Underwriter or counsel for the Underwriter shall reasonably object. The Company will furnish to the Underwriter
such number of copies of such amendment or supplement as the Underwriter may reasonably request. The Company has given the Underwriter
notice of any filings made pursuant to the Exchange Act or the Exchange Act Regulations within 48 hours prior to the Applicable Time.
The Company shall give the Underwriter notice of its intention to make any such filing from the Applicable Time until the later of the
Closing Date and the exercise in full or expiration of the Over-allotment Option specified in Section 1.2 hereof and will furnish the
Underwriter with copies of any such related document(s) a reasonable amount of time prior to such proposed filing, as the case may be,
and will not file or use any such document to which the Underwriter or counsel for the Underwriter shall reasonably object.
3.2.3 Exchange
Act Registration. For a period of three (3) years after the date of this Agreement, the Company shall use its reasonable best efforts
to maintain the registration of the Common Stock under the Exchange Act (including, without limitation, refraining from voluntarily deregistering
such Common Stock), provided that such provision shall not prevent a sale, merger or similar transaction involving the Company.
3.2.4 Free
Writing Prospectuses. The Company agrees that, unless it obtains the prior written consent of the Underwriter, it shall not make
any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a
“free writing prospectus,” or a portion thereof, required to be filed by the Company with the Commission or retained by
the Company under Rule 433; provided that the Underwriter shall be deemed to have consented to each Issuer General Use Free Writing
Prospectus hereto and any “road show that is a written communication” within the meaning of Rule 433(d)(8)(i) that has
been reviewed by the Underwriter. The Company represents that it has treated or agrees that it will treat each such free writing
prospectus consented to, or deemed consented to, by the Underwriter as an “issuer free writing prospectus,” as defined
in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including
timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free
Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration Statement or included or would include an untrue
statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in
light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Underwriter and
will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict,
untrue statement or omission.
3.3 Delivery
to the Underwriter of Registration Statements. The Company has delivered or made available or, at the request of the Underwriter,
shall deliver or make available to the Underwriter and counsel for the Underwriter without charge, signed copies of the Registration Statement
as originally filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates
of experts. The copies of the Registration Statement and each amendment thereto furnished to the Underwriter will be identical to the
electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.
3.4 Delivery
to the Underwriter of Prospectuses. The Company has delivered or made available or will deliver or make available to the Underwriter,
without charge, as many copies of each Preliminary Prospectus, the Disclosure Package and the Prospectus as such Underwriter reasonably
requested, and the Company hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish
to the Underwriter, without charge, during the period when a prospectus relating to the Securities is (or, but for the exception afforded
by Rule 172 of the Securities Act Regulations, would be) required to be delivered under the Securities Act, such number of copies of the
Prospectus (as amended or supplemented) as the Underwriter may reasonably request. The Preliminary Prospectus, the Disclosure Package
and the Prospectus and any amendments or supplements thereto furnished to the Underwriter will be identical to the electronically transmitted
copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.
3.5 Effectiveness
and Events Requiring Notice to the Underwriter. The Company shall use commercially reasonable efforts to cause the Registration Statement
to remain effective with a current prospectus for at least forty-five (45) days after the Applicable Time, and shall notify the Underwriter
immediately and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii)
of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii)
of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Securities for offering
or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv) of the mailing and delivery
to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt of any comments
or request for any additional information from the Commission; and (vi) of the happening of any event during the period described in this
Section 3.5 that, in the judgment of the Company, makes any statement of a material fact made in the Registration Statement, the Disclosure
Package or the Prospectus untrue or that requires the making of any changes in (a) the Registration Statement in order to make the statements
therein not misleading, or (b) in the Disclosure Package or the Prospectus in order to make the statements therein not misleading. If
the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company shall
make every reasonable effort to obtain promptly the lifting of such order.
3.6 Listing.
The Company shall use its commercially reasonable efforts to maintain the listing of the Common Stock (including the Shares) on the Exchange
for at least three (3) years from the date of this Agreement; provided that such provision shall not prevent a sale, merger or similar
transaction involving the Company.
3.7 Payment of Expenses.
3.7.1 General
Expenses Related to the Offering. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if
any, to the extent not paid at the Closing Date, all reasonable, necessary, documented and accountable out-of-pocket expenses to the
extent relating to the performance of the obligations of the Company under this Agreement, including, but not limited to: (a) all
filing fees and communication expenses relating to the registration of the Shares to be issued and sold in the Offering with the
Commission; (b) all filing fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating to the
listing of the Shares on the Exchange; (d) all fees, expenses and disbursements relating to the registration or qualification of the
Securities under the “blue sky” securities laws of such states and other jurisdictions as the Underwriter may reasonably
designate (including, without limitation, all filing and registration fees, and the reasonable fees and disbursements of “blue
sky” counsel which will be the Underwriter’s Counsel) unless such filings are not required; (e) all fees, expenses and
disbursements relating to the registration, qualification or exemption of the Shares under the securities laws of such foreign
jurisdictions as the Underwriter may reasonably designate; (f) the costs of all mailing and printing of the underwriting documents
(including, without limitation, the Underwriting Agreement and any Blue Sky Surveys), Registration Statements, Preliminary
Prospectuses, Disclosure Packages and Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and
final Prospectuses as the Underwriter may reasonably deem necessary; (g) the costs of preparing, printing and delivering
certificates representing the Shares; (h) fees and expenses of the Company’s transfer agent; (j) stock transfer and/or stamp
taxes, if any, payable upon the transfer of securities from the Company to the Underwriter; (k) the fees and expenses of the
Company’s accountants; (l) the fees and expenses of the Company’s legal counsel and other agents and representatives;
and (m) reasonable legal fees and disbursements incurred by the Underwriter in furtherance of the Offering, provided that the
maximum amount of such legal fees for which the Company will be responsible shall not exceed: (x) $75,000 in the event there is a
closing of the Offering; or (y) $30,000 in the event there is not a closing of the Offering. The Underwriter may deduct from the net
proceeds of the Offering payable to the Company on the Closing Date, or the Option Closing Date, if any, the undisputed fees and
expenses set forth herein to be paid by the Company to the Underwriter.
3.8 Application
of Net Proceeds. The Company shall apply the net proceeds from the Offering received by it in a manner consistent with the application
thereof described under the caption “Use of Proceeds” in the Registration Statement, the Disclosure Package and the Prospectus.
3.9 Stabilization.
Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Underwriter) has
taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause
or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities.
3.10 Internal
Controls. The Company shall use commercially reasonable efforts to maintain and shall cause each of its Subsidiaries to maintain a
system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with
management’s general or specific authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial
statements in accordance with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with
management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets
at reasonable intervals and appropriate action is taken with respect to any differences.
3.11 Accountants.
As of the date of this Agreement, the Company shall retain an independent registered public accounting firm, as required by the Securities
Act and the Securities Act Regulations and the Public Company Accounting Oversight Board, reasonably acceptable to the Underwriter, and
the Company shall continue to retain an independent registered public accounting firm for a period of at least three (3) years after the
date of this Agreement. The Underwriter acknowledges that the Auditor is acceptable to the Underwriter.
3.12 FINRA.
For a period of 90 days from the later of the Closing Date or the Option Closing Date (if any), the Company shall advise the Underwriter
(who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or director of the Company, (ii) any
beneficial owner of 5% or more of any class of the Company’s securities or (iii) any beneficial owner of the Company’s unregistered
equity securities which were acquired during the 180 days immediately preceding the filing of the Registration Statement is or becomes
an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations
of FINRA).
3.13 No
Fiduciary Duties. The Company acknowledges and agrees that the Underwriter’s responsibility to the Company is solely contractual
in nature and that none of the Underwriter or its affiliates or any selling agent shall be deemed to be acting in a fiduciary capacity,
or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other transactions
contemplated by this Agreement.
3.14 Company
Standstill. the Company agrees, for a period of sixty (60) days from the Closing Date of the Offering, that without the prior written
consent of the Underwriter, it will not (a) offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, any equity
of the Company or any securities convertible into or exercisable or exchangeable for equity of the Company; (b) file or caused to be filed
any registration statement with the Commission relating to the offering of any equity of the Company or any securities convertible into
or exercisable or exchangeable for equity of the Company; or (c) enter into any agreement or announce the intention to effect any of the
actions described in subsections (a) or (b) hereof (all of such matters, the “Standstill”). So long as none of such
equity securities shall be saleable in the public market until the expiration of the sixty (60) day period described above, the following
matters shall not be prohibited by the Standstill: (i) the adoption of an equity incentive plan and the grant of awards or equity pursuant
to any equity incentive plan, and the filing of a registration statement on Form S- 8; (ii) the issuance of securities of the Company
upon exercise, vesting, settlement or conversion of securities or contracts of the Company outstanding on the closing date and (iii) the
issuance of equity securities in connection with an acquisition or a strategic relationship, which may include the sale of equity securities.
In no event should any equity transaction during the Standstill period result in the sale of equity at an offering price to the public
less than that of the Offering referred herein.
3.15 Release
of D&O Lock-up Period. If the Underwriter, in its sole discretion, agrees to release or waive the restrictions set forth in the
Lock-Up Agreements described in Section 2.27 hereof for an officer, director or shareholder of the Company, the Underwriter shall provide
the Company with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or
waiver, the Company agrees if required by applicable law to announce the impending release or waiver by a press release substantially
in the form of Exhibit A hereto through a major news service at least two (2) Business Days before the effective date of the release
or waiver.
3.16 Blue
Sky Qualifications. The Company shall use its best efforts, in cooperation with the Underwriter, if necessary, to qualify the Securities
for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Underwriter
may designate and to maintain such qualifications in effect so long as required to complete the distribution of the Securities; provided,
however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation
or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing
business in any jurisdiction in which it is not otherwise so subject.
3.17 Reporting
Requirements. The Company, during the period when a prospectus relating to the Securities is (or, but for the exception afforded by
Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed with the Commission
pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations.
3.18 Press
Releases. Prior to the date that is 45 days after the Closing Date, the Company shall not issue any press release or other communication
directly or indirectly or hold any press conference with respect to the Company, its condition, financial or otherwise, or earnings, business
affairs or business prospects (except for routine oral or written marketing communications or press releases in the ordinary course of
business and consistent with the past practices of the Company and of which the Underwriter is notified in advance), without the prior
written consent of the Underwriter, which consent shall not be unreasonably withheld, unless in the judgment of the Company and its counsel,
and after notification to the Underwriter, such press release or communication is required by law.
3.19 Reserved.
4. Conditions
of Underwriter’s Obligations. The obligations of the Underwriter to purchase and pay for the Securities, as provided herein,
shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date hereof and as of each
of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the Company made pursuant
to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following conditions:
4.1 Regulatory
Matters; Absence of Certain Commission Actions; Required Filings. At each of the Closing Date and any Option Closing
Date, no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been
issued or shall have been issued under the Securities Act, no order preventing or suspending the use of any Preliminary Prospectus
or the Prospectus has been issued or shall have been issued and no proceedings for any of those purposes have been instituted or are
pending or, to the Company’s knowledge, contemplated by the Commission. The Company has complied with each request (if any)
from the Commission for additional information. A prospectus containing the Rule 430B Information shall have been filed with the
Commission in the manner and within the time frame required by Rule 424(b) under the Securities Act Regulations (without reliance on
Rule 424(b)(8)) or a post-effective amendment providing such information shall have been filed with, and declared effective by, the
Commission in accordance with the requirements of Rule 430B under the Securities Act Regulations.
4.2 Company Counsel Matters.
4.2.1 Closing
Date Opinion of Counsel to the Company. On the Closing Date, the Underwriter shall have received the favorable opinion of Baker Hostetler,
and a written statement providing certain “10b-5” negative assurances, dated the Closing Date and addressed to the Underwriter,
in a form and substance reasonably satisfactory to the Underwriter.
4.2.2 Option
Closing Date Opinion of Counsel. On the Option Closing Date, if any, the Underwriter shall have received the favorable opinion of
counsel listed in Section 4.2.1, dated the Option Closing Date, addressed to the Underwriter and in form and substance reasonably satisfactory
to the Underwriter, confirming as of the Option Closing Date, the statements made by such counsel in its opinion delivered on the Closing
Date.
4.2.3 Reliance.
In rendering such opinions, such counsel may rely: (i) as to matters involving the application of laws other than the laws of the United
States and jurisdictions in which they are admitted, to the extent such counsel deems proper and to the extent specified in such opinion,
if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the Underwriter) of other counsel reasonably
acceptable to the Underwriter, familiar with the applicable laws; and (ii) as to matters of fact, to the extent they deem proper, on certificates
or other written statements of officers of the Company and officers of departments of various jurisdictions having custody of documents
respecting the corporate existence or good standing of the Company, provided that copies of any such statements or certificates shall
be delivered to Underwriter’s Counsel if requested. The opinion referred to in Sections 4.2.1 above and any related Option Closing
Date opinion shall include a statement to the effect that it may be relied upon by Underwriter’s Counsel in its written statement
providing certain “10b-5” negative assurances delivered to the Underwriter.
4.3 Comfort Letters
4.3.1 CFO
Certificate. At the time of this Agreement, the Underwriter shall have received a certificate from the Chief Financial Officer of
the Company containing statements and information with respect to the financial statements and certain financial information contained
in the Registration Statement, the Disclosure Package and the Prospectus, addressed to the Underwriter and in form and substance satisfactory
in all respects to the Underwriter and to Underwriter’s Counsel from the Auditors, dated as of the date of this Agreement.
4.3.2 Cold
Comfort Letter. At the time of the Closing Date, the Underwriter shall have received a cold comfort certificate containing statements
and information of the type customarily included in accountants’ comfort letters with respect to the financial statements and certain
financial information contained in the Registration Statement, the Disclosure Package and the Prospectus, addressed to the Underwriter
and in form and substance satisfactory in all respects to the Underwriter and to Underwriter’s Counsel from the Auditors, dated
as of the date of the Closing Date.
4.3.3 Bring-down
Comfort Letter. At each Option Closing Date, if any, the Underwriter shall have received from the Auditor a letter, dated as of the
Option Closing Date, to the effect that the Auditor reaffirms the statements made in the letter furnished pursuant to Section 4.3.2, except
that the specified date referred to shall be a date not more than one (1) Business Day prior to the Option Closing Date.
4.4 Officers’ Certificates.
4.4.1 Officers’
Certificate. The Company shall have furnished to the Underwriter a certificate, dated the Closing Date and any Option Closing Date
(if such date is other than the Closing Date), of its Chief Executive Officer and its Chief Financial Officer stating that (i) such officers
have carefully examined the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and,
in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time, as of the date of this Agreement and
as of the Closing Date (or any Option Closing Date if such date is other than the Closing Date) did not include any untrue statement of
a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading, and the Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date if such date
is other than the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option Closing Date
if such date is other than the Closing Date), the Prospectus and each amendment or supplement thereto, as of the respective date thereof
and as of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary
in order to make the statements therein, in light of the circumstances in which they were made, not misleading, (ii) since the effective
date of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment to the Registration
Statement, the Disclosure Package or the Prospectus, (iii) to the best of their knowledge after reasonable investigation, as of the Closing
Date (or any Option Closing Date if such date is other than the Closing Date), the representations and warranties of the Company in this
Agreement are true and correct in all material respects (except for those representations and warranties qualified as to materiality,
which shall be true and correct in all respects, and except for those representations and warranties that refer to facts existing at a
specific date, which shall be true and correct as of such date) and the Company has complied with all agreements and satisfied all conditions
on its part to be performed or satisfied hereunder at or prior to the Closing Date (or any Option Closing Date if such date is other than
the Closing Date), and (iv) there has not been, subsequent to the date of the most recent audited financial statements included or incorporated
by reference in the Disclosure Package, a Material Adverse Change.
4.4.2 Secretary’s
Certificate. At each of the Closing Date and the Option Closing Date, if any, the Underwriter shall have received a certificate of
the Company signed by the Secretary of the Company, dated the Closing Date or the Option Date, as the case may be, respectively, certifying:
(i) that each of the Charter and Bylaws is true and complete, has not been modified and is in full force and effect; (ii) that the resolutions
of the Company’s Board of Directors relating to the Offering are in full force and effect and have not been modified; (iii) as to
the accuracy and completeness of all correspondence between the Company or its counsel and the Commission; and (iv) as to the incumbency
of the officers of the Company. The documents referred to in such certificate shall be attached to such certificate.
4.5 No
Material Changes. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been no Material
Adverse Change or development that may be reasonably expected to cause a Material Adverse Change from the latest dates as of which such
condition is set forth in the Registration Statement and no material change in the capital stock or debt of the Company, the Disclosure
Package and the Prospectus; (ii) no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the
Company or, to the Company’s knowledge, any Insider before or by any court or federal or state commission, board or other administrative
agency wherein an unfavorable decision, ruling or finding may reasonably be expected to cause a Material Adverse Change; (iii) no stop
order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened by the Commission;
(iv) no action shall have been taken and no law, statute, rule, regulation or order shall have been enacted, adopted or issued by any
Governmental Entity which would prevent the issuance or sale of the Securities or may reasonably be expected to cause a Material Adverse
Change; (v) no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall
have been issued which would prevent the issuance or sale of the Securities or may reasonably be expected to cause a Material Adverse
Change; and (vi) the Registration Statement, the Disclosure Package and the Prospectus and any amendments or supplements thereto shall
contain all material statements which are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations
and shall conform in all material respects to the requirements of the Securities Act and the Securities Act Regulations, and none of the
Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus or any amendment or supplement thereto
shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were made, not misleading.
4.6 No
Material Misstatement or Omission. The Underwriter shall not have discovered and disclosed to the Company on or prior to the Closing
Date and any Option Closing Date that the Registration Statement or any amendment or supplement thereto contains an untrue statement of
a fact which, in the opinion of counsel for the Underwriter, is material or omits to state any fact which, in the opinion of such counsel,
is material and is required to be stated therein or is necessary to make the statements therein not misleading, or that the Registration
Statement, the Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus or any amendment or supplement thereto contains
an untrue statement of fact which, in the opinion of such counsel, is material or omits to state any fact which, in the opinion of such
counsel, is material and is necessary in order to make the statements, in light of the circumstances under which they were made, not misleading.
4.7 Corporate
Proceedings. All corporate proceedings and other legal matters incident to the authorization, form and validity of each of this Agreement,
the Securities, the Registration Statement, the Disclosure Package, each Issuer Free Writing Prospectus, if any, and the Prospectus and
all other legal matters relating to this Agreement and the transactions contemplated hereby and thereby shall be reasonably satisfactory
in all material respects to counsel for the Underwriter, and the Company shall have furnished to such counsel all documents and information
that they may reasonably request to enable them to pass upon such matters.
4.8 Delivery
of Lock-Up Agreements. On or before the date of this Agreement, the Company shall have delivered to the Underwriter executed copies
of the Lock-Up Agreements from each of the persons listed in Schedule 3 hereto.
4.9 Good
Standing Certificates. On the Closing Date and the Option Closing Date, if any, the Company shall have delivered to the Underwriter
(i) a certificate of good standing from the State of Delaware as of a date within ten (10) days of the Closing Date for the Company (ii)
a certificate of fact (or equivalent) as of a date within ten (10) days of the Closing Date from the respective jurisdictions for each
of the Company’s Subsidiaries.
4.10. Delivery
of Pre-funded Warrants. On the Closing Date, the Company shall have delivered to the Underwriter executed copies of the Pre-funded
Warrants.
4.11. Delivery
of the Warrant Agent Agreement. On the Closing Date, the Company and the Warrant Agent shall have executed the Warrant Agent Agreement
regarding the Pre-funded Warrants and the Warrant Agent Agreement shall be in full force and effect.
4.12 Additional
Documents. At the Closing Date and at each Option Closing Date (if any), Underwriter’s Counsel shall have been furnished with
such documents and opinions as they may require for the purpose of enabling Underwriter’s Counsel to deliver an opinion to the Underwriter,
or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, herein
contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated
shall be satisfactory in form and substance to the Underwriter and Underwriter’s Counsel.
5. Indemnification.
5.1 Indemnification
by the Company. The Company shall indemnify and hold harmless the Underwriter, its affiliates and each of its and their
respective directors, officers, members, employees, representatives and agents and each person, if any, who controls any Underwriter
within the meaning of Section 15 of the Securities Act of or Section 20 of the Exchange Act (collectively the “Underwriter
Indemnified Parties,” and each a “Underwriter Indemnified Party”) against any loss, claim, damage,
expense or liability whatsoever (or any action, investigation or proceeding in respect thereof), to which such Underwriter
Indemnified Party may become subject, under the Securities Act or otherwise, to the extent such loss, claim, damage, expense,
liability, action, investigation or proceeding is caused by (A) any untrue statement or alleged untrue statement of a material fact
contained in any Registration Statement, Preliminary Prospectus, Disclosure Package, Issuer Free Writing Prospectus, any
“issuer information” filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations, or
the Prospectus, or in any amendment or supplement thereto or document incorporated by reference therein, or (B) the omission or
alleged omission to state in any Registration Statement, Preliminary Prospectus, Disclosure Package, Issuer Free Writing Prospectus,
any “issuer information” filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations,
or the Prospectus, or in any amendment or supplement thereto or document incorporated by reference therein, a material fact required
to be stated therein or necessary to make the statements therein not misleading (in the case of the Preliminary Prospectus,
Disclosure Package, Issuer Free Writing Prospectus, any “issuer information” filed or required to be filed
pursuant to Rule 433(d) of the Securities Act Regulations, or the Prospectus, in light of the circumstances in which such statements
were made), and shall reimburse the Underwriter Indemnified Party promptly upon demand for any legal fees or other expenses
reasonably incurred by that Underwriter Indemnified Party in connection with investigating, or preparing to defend, or defending
against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim,
damage, expense, liability, action, investigation or proceeding, as such fees and expenses are incurred; provided, however,
that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, expense or liability arises
out of or is based upon an untrue statement in, or omission from any Registration Statement, Preliminary Prospectus, Disclosure
Package, Issuer Free Writing Prospectus or the Prospectus, or any such amendment or supplement thereto, or made in reliance upon and
in conformity with written information furnished to the Company by or on behalf of the Underwriter specifically for use therein,
which information the parties hereto agree is limited to the Underwriter’s Information. This indemnity agreement is not
exclusive and will be in addition to any liability, which the Company might otherwise have and shall not limit any rights or
remedies which may otherwise be available at law or in equity to each Underwriter Indemnified Party.
5.2 Indemnification
by the Underwriter. The Underwriter agrees to indemnify and hold harmless the Company, its directors, its officers who signed the
Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act (collectively the “Company Indemnified Parties” and each a “Company Indemnified Party”)
against any loss, claim, damage, expense or liability whatsoever (or any action, investigation or proceeding in respect thereof), to which
such Company Indemnified Party may become subject, under the Securities Act or otherwise, to the extent such loss, claim, damage, expense,
liability, action, investigation or proceeding is caused by (i) any untrue statement of a material fact contained in any Registration
Statement, Preliminary Prospectus, Disclosure Package, Issuer Free Writing Prospectus, any “issuer information” filed
or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations, or the Prospectus, or in any amendment or supplement
thereto, or (ii) the omission to state in any Registration Statement, Preliminary Prospectus, Disclosure Package, Issuer Free Writing
Prospectus, any “issuer information” filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations,
or the Prospectus, or in any amendment or supplement thereto, a material fact required to be stated therein or necessary to make the statements
therein not misleading (in the case of the Preliminary Prospectus, Disclosure Package, Issuer Free Writing Prospectus, any “issuer
information” filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations, or the Prospectus, in
light of the circumstances in which such statements were made), but in each case only to the extent that the untrue statement or omission
was made in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Underwriter, which
information the parties hereto agree is limited to the Underwriter’s Information and shall reimburse the Company for any legal or
other expenses reasonably incurred by such party in connection with investigating or preparing to defend or defending against or appearing
as third party witness in connection with any such loss, claim, damage, liability, action, investigation or proceeding, as such fees and
expenses are incurred. Notwithstanding the provisions of this Section 5.2, in no event shall any indemnity by an Underwriter under this
Section 5.2 exceed the total discount and commission received by such Underwriter in connection with the Offering.
5.3 Procedure.
Promptly after receipt by an indemnified party under this Section 5 of notice of the commencement of any action, the indemnified
party shall, if a claim in respect thereof is to be made against an indemnifying party under this Section 5, notify such
indemnifying party in writing of the commencement of that action; provided, however, that the failure to notify the
indemnifying party shall not relieve it from any liability which it may have under this Section 5 except to the extent it has been
materially adversely prejudiced by such failure; and, provided, further, that the failure to notify an indemnifying
party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Section 5. If any
such action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying
party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified
indemnifying party, to assume the defense of such action with counsel reasonably satisfactory to the indemnified party (which
counsel shall not, except with the written consent of the indemnified party, be counsel to the indemnifying party). After notice
from the indemnifying party to the indemnified party of its election to assume the defense of such action, except as provided
herein, the indemnifying party shall not be liable to the indemnified party under Section 5 for any legal or other expenses
subsequently incurred by the indemnified party in connection with the defense of such action other than reasonable costs of
investigation; provided, however, that any indemnified party shall have the right to employ separate counsel in any
such action and to participate in the defense of such action but the fees and expenses of such counsel (other than reasonable costs
of investigation) shall be at the expense of such indemnified party unless (i) the employment thereof has been specifically
authorized in writing by the Company in the case of a claim for indemnification under 5.1 or the Underwriter in the case of a claim
for indemnification under Section 5.2, (ii) such indemnified party shall have been advised by its counsel that there may be one or
more legal defenses available to it which are different from or additional to those available to the indemnifying party, or (iii)
the indemnifying party has failed to assume the defense of such action and employ counsel reasonably satisfactory to the indemnified
party within a reasonable period of time after notice of the commencement of the action or the indemnifying party does not
diligently defend the action after assumption of the defense, in which case, if such indemnified party notifies the indemnifying
party in writing that it elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall
not have the right to assume the defense of (or, in the case of a failure to diligently defend the action after assumption of the
defense, to continue to defend) such action on behalf of such indemnified party and the indemnifying party shall be responsible for
legal or other expenses subsequently incurred by such indemnified party in connection with the defense of such action; provided, however,
that the indemnifying party shall not, in connection with any one such action or separate but substantially similar or related
actions in the same jurisdiction arising out of the same general allegations or circumstances, be liable for the reasonable fees and
expenses of more than one separate firm of attorneys at any time any such indemnified party (in addition to any local counsel),
which firm shall be designated in writing by the Underwriter if the indemnified party under this Section 5 is an Underwriter
Indemnified Party or by the Company if an indemnified party under this Section 5 is a Company Indemnified Party. Subject to this
Section 5.3, the amount payable by an indemnifying party under Section 5 shall include, but not be limited to, (x) reasonable legal
fees and expenses of counsel to the indemnified party and any other expenses in investigating, or preparing to defend or defending
against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any action, investigation,
proceeding or claim, and (y) all amounts paid in settlement of any of the foregoing. No indemnifying party shall, without the prior
written consent of the indemnified parties, settle or compromise or consent to the entry of judgment with respect to any pending or
threatened action or any claim whatsoever, in respect of which indemnification or contribution could be sought under this Section 5
(whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i)
includes an unconditional release of each indemnified party in form and substance reasonably satisfactory to such indemnified party
from all liability arising out of such action or claim and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party. Subject to the provisions of the following sentence, no
indemnifying party shall be liable for settlement of any pending or threatened action or any claim whatsoever that is effected
without its written consent (which consent shall not be unreasonably withheld or delayed), but if settled with its written consent,
if its consent has been unreasonably withheld or delayed or if there be a judgment for the plaintiff in any such matter, the
indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of
such settlement or judgment. In addition, if at any time an indemnified party shall have requested that an indemnifying party
reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any
settlement of the nature contemplated herein effected without its written consent if (i) such settlement is entered into more than
forty- five (45) days after receipt by such indemnifying party of the request for reimbursement, (ii) such indemnifying party shall
have received notice of the terms of such settlement at least thirty (30) days prior to such settlement being entered into and (iii)
such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such
settlement.
5.4 Contribution.
If the indemnification provided for in this Section 5 is unavailable or insufficient to hold harmless an indemnified party under
Section 5.1 or Section 5.2, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the
amount paid, payable or otherwise incurred by such indemnified party as a result of such loss, claim, damage, expense or liability
(or any action, investigation or proceeding in respect thereof), as incurred, (i) in such proportion as shall be appropriate to
reflect the relative benefits received by the Company on the one hand and the Underwriter on the other hand from the Offering, or
(ii) if the allocation provided by clause (i) of this Section 5.4 is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i) of this Section 5.4 but also the relative fault of
the Company on the one hand and the Underwriter on the other with respect to the statements, omissions, acts or failures to act
which resulted in such loss, claim, damage, expense or liability (or any action, investigation or proceeding in respect thereof) as
well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the
Underwriter on the other with respect to the Offering shall be deemed to be in the same proportion as the total proceeds from the
Offering purchased under this Agreement (before deducting expenses) received by the Company bear to the total underwriting discount
and commissions received by the Underwriter in connection with the Offering, in each case as set forth in the table on the cover
page of the Prospectus. The relative fault of the Company on the one hand and the Underwriter on the other shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company on the one hand or the Underwriter on the other,
the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue
statement, omission, act or failure to act; provided that the parties hereto agree that the written information furnished to the
Company by or on behalf of the Underwriter for use in any Preliminary Prospectus, any Registration Statement or the Prospectus, or
in any amendment or supplement thereto, consists solely of the Underwriter’s Information. The Company and the Underwriter
agree that it would not be just and equitable if contributions pursuant to this Section 5.4 be determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid
or payable by an indemnified party as a result of the loss, claim, damage, expense, liability, action, investigation or proceeding
referred to above in this Section 5.4 shall be deemed to include, for purposes of this Section 5.4, any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating, preparing to defend or defending against or
appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim, damage, expense,
liability, action, investigation or proceeding. Notwithstanding the provisions of this Section 5.4, no Underwriter shall be required
to contribute any amount in excess of the total discount and commission received by such Underwriter in connection with the Offering
less the amount of any damages which such Underwriter has otherwise paid or become liable to pay by reason of any untrue or alleged
untrue statement, omission or alleged omission, act or alleged act or failure to act or alleged failure to act. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation. The Underwriter’s obligation to contribute as provided in this
Section
5.4 are several and in proportion to their
respective underwriting obligation, and not joint
6. Default by an Underwriter.
6.1 Default.
If the Underwriter defaults in its obligation to purchase the Firm Securities or the Option Shares, if the Over-allotment Option is exercised
hereunder, you may in your discretion arrange for yourself or for another party or parties to purchase such Firm Securities or Option
Shares to which such default relates on the terms contained herein. If, within one (1) Business Day after such default relating to more
than 10% of the Firm Securities or Option Shares, you do not arrange for the purchase of such Firm Securities or Option Shares, then the
Company shall be entitled to a further period of one (1) Business Day within which to procure another party or parties satisfactory to
you to purchase said Firm Securities or Option Shares on such terms. In the event that neither you nor the Company arrange for the purchase
of the Firm Securities or Option Shares to which a default relates as provided in this Section 6, this Agreement will automatically be
terminated by you or the Company without liability on the part of the Company (except as provided in Sections 3.7 and 5 hereof) or the
Underwriter (except as provided in Section 5 hereof); provided, however, that if such default occurs with respect to the
Option Shares, this Agreement will not terminate as to the Firm Securities.
6.2 Postponement
of Closing Date. In the event that the Firm Securities or Option Shares to which the default relates are to be purchased by another
party or parties as aforesaid, you or the Company shall have the right to postpone the Closing Date or Option Closing Date for a reasonable
period, but not in any event exceeding five (5) Business Days, in order to effect whatever changes may thereby be made necessary in the
Registration Statement, the Disclosure Package or the Prospectus or in any other documents and arrangements, and the Company agrees to
file promptly any amendment to the Registration Statement, the Disclosure Package or the Prospectus that in the opinion of counsel for
the Underwriter may thereby be made necessary. The term “Underwriter” as used in this Agreement shall include any party
substituted under this Section 6 with like effect as if it had originally been a party to this Agreement with respect to such Securities.
7. Reserved.
8. Effective Date of this Agreement and Termination Thereof.
8.1 Effective
Date. This Agreement shall become effective when both the Company and the Underwriter have executed the same and delivered counterparts
of such signatures to the other party.
8.2 Termination.
The Underwriter shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if any domestic or international
event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially disrupt, general securities
markets in the United States; or (ii) if trading on the New York Stock Exchange or the Nasdaq Stock Market LLC shall have been suspended
or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall
have been required by FINRA or by order of the Commission or any other government authority having jurisdiction; or (iii) if the United
States shall have become involved in a new war or an increase in major hostilities; or (iv) if a banking moratorium has been declared
by a New York State or federal authority; or (v) if a moratorium on foreign exchange trading has been declared which materially adversely
impacts the United States securities markets; or (vi) if the Company shall have sustained a material loss by fire, flood, accident, hurricane,
earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will, in your
opinion, make it inadvisable to proceed with the delivery of the Firm Shares or Option Shares; or (vii) if the Company is in material
breach of any of its representations, warranties or covenants hereunder; or (viii) if any condition set forth in Section 4 hereof is not
satisfied on or prior to any Closing Date; or (ix) if the Underwriter shall have become aware after the date hereof of such a Material
Adverse Change in the conditions of the Company, or such adverse material change in general market conditions as in the Underwriter’s
judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Securities or to enforce contracts made
by the Underwriter for the sale of the Securities.
8.3 Expenses
Upon Termination. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriter,
pursuant to Section 6.1 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified
herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriter its actual and
accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable (including the fees and disbursements
of Underwriter’s Counsel) up to $30,000, and upon demand the Company shall pay the full amount of any such undisputed expenses to
the Underwriter; provided, however, that such expense cap in no way limits or impairs the indemnification and contribution
provisions of this Agreement.
8.4 Survival
of Indemnification. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination
of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in full force
and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this Agreement or
any part hereof.
8.5 Representations,
Warranties, Agreements to Survive. All representations, warranties and agreements contained in this Agreement or in certificates of
officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i) any investigation
made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter, its officers or directors
or any person controlling the Company or (ii) delivery of and payment for the Securities.
9. Miscellaneous.
9.1 Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given
(a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail if sent during normal business hours
of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with an internationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. Notices shall be addressed to the respective parties as follows, or
to such other address as a party shall specify to the others in accordance with these notice provisions.
If to the Underwriter:
Aegis Capital Corp.
1345 Avenue of the Americas, 27th Floor
New York, NY
10105
Attn: Robert J. Eide, Chief Executive Officer
Email:
reide@aegiscap.com
with a copy (which shall not constitute notice) to:
Kaufman & Canoles, P.C.
Two James Center, 14th Floor
1021 E. Cary St.
Richmond, VA 23219
Attn: Anthony W. Basch, Esq.
Email: awbasch@kaufcan.com
If to the Company:
Nuvve Holding Corp.
2488 Historic Decatur Road, Suite 200
San Diego, CA 92106
Email: gregory@nuvve.com
Attention: Gregory Poilasne
with a copy (which shall not constitute notice) to:
Baker Hostetler
11601 Wilshire Boulevard
Suite 1400
Los Angeles, CA 90025
Email: jrlanis@bakerlaw.com
Attention: JR Lanis
9.2 Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Agreement.
9.3 Absence of Fiduciary Relationship. The Company acknowledges and agrees that:
(i) the
Underwriter’s responsibility to the Company is solely contractual in nature, the Underwriter has been retained solely to act as
an underwriter in connection with the Offering and no fiduciary, advisory or agency relationship between the Company and the Underwriter
has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Underwriter has advised
or is advising the Company on other matters;
(ii) the
price of the Securities set forth in this Agreement was established by the Company following discussions and arms-length negotiations
with the Underwriter, and the Company is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions
of the transactions contemplated by this Agreement; and
(iii) it
has been advised that the Underwriter and their respective affiliates are engaged in a broad range of transactions which may involve interests
that differ from those of the Company and that the Underwriter have no obligation to disclose such interests and transactions to the Company
by virtue of any fiduciary, advisory or agency relationship.
9.4 Research
Analyst Independence. The Company acknowledges that the Underwriter’s research analysts and research departments are
required to be independent from its investment banking division and are subject to certain regulations and internal policies, and
that such Underwriter’s research analysts may hold views and make statements or investment recommendations and/or publish
research reports with respect to the Company and/or the offering that differ from the views of their investment banking division.
The Company acknowledges that the Underwriter is a full service securities firm and as such from time to time, subject to applicable
securities laws, rules and regulations, may effect transactions for its own account or the account of its customers and hold long or
short positions in debt or equity securities of the Company; provided, however, that nothing in this Section 9.4 shall
relieve the Underwriter of any responsibility or liability it may otherwise bear in connection with activities in violation of
applicable securities laws, rules or regulations.
9.5 Amendment.
This Agreement may only be amended by a written instrument executed by each of the parties hereto.
9.6 Entire
Agreement. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this
Agreement) constitutes the entire agreement of the parties hereto with respect to the Offering subject matter hereof and thereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to this Offering and matters related
thereto. Nothing in this Agreement shall abrogate or affect any rights or obligations of the parties arising out of or related to any
other agreements between the parties unrelated to this Offering.
9.7 Binding
Effect. This Agreement shall inure solely to the benefit of and shall be binding upon the Underwriter, the Company and the controlling
persons, directors and officers referred to in Section 5 hereof, and their respective successors, legal representatives, heirs and assigns,
and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue
of this Agreement or any provisions herein contained. The term “successors and assigns” shall not include a purchaser, in
its capacity as such, of securities from the Underwriter.
9.8 Governing
Law; Consent to Jurisdiction; Trial by Jury. This Agreement shall be governed by and construed and enforced in accordance with the
laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action,
proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in the New York
Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, and irrevocably submits
to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and
that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in
Section 9.1 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company agrees that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies)
all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with the
preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates)
and the Underwriter hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in
any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
9.9 Execution
in Counterparts. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts,
each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall
become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other parties
hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall constitute valid and sufficient
delivery thereof.
9.10 Waiver,
etc. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or
construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision hereof or the
right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by
the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.
9.11 Equitable
Remedies. Each party to this Agreement acknowledges and agrees that (a) a breach or threatened breach by the Company of any of its
obligations under Section 3.14 would give rise to irreparable harm to the Underwriter for which monetary damages would not be an adequate
remedy and (b) if a breach or a threatened breach by the Company of any such obligations occurs, the Underwriter will, in addition to
any and all other rights and remedies that may be available to such party at law, at equity, or otherwise in respect of such breach, be
entitled to equitable relief, including a temporary restraining order, an injunction, specific performance of the terms of Section 3.14,
and any other relief that may be available from a court of competent jurisdiction, without any requirement to (i) post a bond or other
security, or (ii) prove actual damages or that monetary damages will not afford an adequate remedy. Each party to this Agreement agrees
that such party shall not oppose or otherwise challenge the existence of irreparable harm, the appropriateness of equitable relief or
the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this
Section 9.11.
[Signature Page Follows]
If the foregoing correctly sets forth the
understanding between the Underwriter and the Company, please so indicate in the space provided below for that purpose, whereupon this
letter shall constitute a binding agreement between us.
|
Very truly yours, |
|
|
|
NUVVE HOLDING CORP. |
|
|
|
|
By: |
/s/ Gregory Poilasne |
|
Name: |
Gregory Poilasne |
|
Title: |
Chief Executive Officer |
Confirmed as of the date first written above:
AEGIS CAPITAL CORP. |
|
|
|
|
By: |
/s/ Robert J. Eide |
|
Name: |
Robert J. Eide |
|
Title: |
Chief Executive Officer |
|
SCHEDULE 1
Underwriter | |
Total Number of Firm Shares or Pre-funded Warrants to be Purchased | | |
Number of Option Shares to be Purchased if Over-Allotment Option is Fully Exercised | |
Aegis Capital Corp. | |
| 7,142,857 | | |
| 1,071,429 | |
SCHEDULE 2-A
Pricing Information
Number of Firm Shares: | |
| 7,142,857 | |
Number of Pre-funded Warrants: | |
| 0 | |
Number of Option Shares: | |
| 1,071,429 | |
Public Offering Price per Firm Share or Option Share: | |
$ | 0.14 | |
Public Offering Price per Pre-funded Warrant: | |
$ | 0.139 | |
Exercise Price per Pre-funded Warrant: | |
$ | 0.001 | |
Underwriting Discount per Firm Share or Option Share: | |
$ | 0.01 | |
Underwriting Discount per Pre-funded Warrant: | |
$ | 0.01 | |
SCHEDULE 2-B
Issuer General Use Free Writing
Prospectuses
None
SCHEDULE 3
List of Lock-Up Parties
List of officers and directors
executing lock-up agreements
Gregory Poilasne
Ted Smith
David G. Robson
Angela Strand
H. David Sherman
Jon M. Montgomery
Rashida La Lande
EXHIBIT A
Form of Press Release
[COMPANY]
[Date]
[COMPANY] (the “Company”)
announced today that Aegis Capital Corp., acting as the Underwriter in the Company’s recent public offering of shares of the Company’s
common stock and prefunded warrants to purchase shares of the Company’s common stock, is [waiving] [releasing] a lock-up restriction
with respect to shares of the Company’s common stock held by [certain officers or directors] [an officer or director] of the Company.
The [waiver] [release] will take effect on [Date], and the shares may be sold on or after such date.
This press release is not an offer
or sale of the securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities
may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933,
as amended.
Exhibit 5.1
October 19, 2023
Nuvve Holding Corp.
2468 Historic Decatur Road
San Diego, CA 92106
Ladies and Gentlemen:
We
have acted as counsel to Nuvve Holding Corp., a Delaware corporation (the “Company”), in connection with the preparation and
filing with the Securities and Exchange Commission (the “Commission”) of a Prospectus Supplement, dated October 18, 2023 (the
“Prospectus Supplement”), to a Prospectus, dated May 5, 2022 (the “Prospectus”), filed pursuant to a Registration
Statement on Form S-3, Registration No. 333-264462 (the “Registration Statement”), pursuant to which the Company is offering
for sale under the Securities Act of 1933, as amended (the “Securities Act”) 7,142,857 shares (the “Firm Shares”)
of common stock, par value $0.0001 per share (the “Common Stock”), all of which will be sold to the Underwriter (as defined
below) pursuant to that certain Underwriting Agreement, dated October 18, 2023 (the “Underwriting Agreement”), between the
Company and Aegis Capital Corp. (the “Underwriter”). Pursuant to the Underwriting Agreement, the
Underwriter also has the option to purchase from the Company to cover over-allotments, if any, up to 1,071,429 additional shares of Common
Stock (together with the Firm Shares, the “Shares”). This opinion is being rendered in connection with the filing of the Prospectus
Supplement with the Commission. All capitalized terms used herein and not otherwise defined shall have the respective meanings given to
them in the Registration Statement.
For purposes of this opinion
letter, we have examined copies of such agreements, instruments and documents as we have deemed an appropriate basis on which to render
the opinions hereinafter expressed. In our examination of the aforesaid documents, we have assumed the genuineness of all signatures,
the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of all original
documents, and the conformity to authentic original documents of all documents submitted to us as copies (including telecopies). As to
all matters of fact, we have relied on the representations and statements of fact made in the documents so reviewed, and we have not independently
established the facts so relied on. This opinion letter is given, and all statements herein are made, in the context of the foregoing.
Based upon the foregoing,
and subject to the limitations set forth below, we are of the opinion that the Shares, when sold and issued in accordance with the Underwriting
Agreement and in the manner contemplated by the Registration Statement and the Prospectus and Prospectus Supplement, will be validly issued,
fully paid and nonassessable.
Our opinion is expressed only
with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable
to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law,
rule or regulation. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim
any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect
any matters or opinions set forth herein.
We have relied as to certain
matters on information obtained from public officials, officers of the Company, and other sources believed by us to be responsible.
We hereby consent to the filing
of this opinion as an exhibit to a Current Report on Form 8-K in accordance with the requirements of Item 601(b)(5) of Regulation S-K
under the Securities Act and to the use of this firm’s name therein and in the Prospectus and Prospectus Supplement under the caption
“Legal Matters.” In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required
under Section 7 of the Securities Act or the rules and regulations of the Commission.
Very truly yours,
/s/ Baker & Hostetler LLP
v3.23.3
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=NVVE_CommonStockParValue0.0001PerShareMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=NVVE_WarrantsToPurchaseCommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Nuvve (NASDAQ:NVVE)
Historical Stock Chart
From Apr 2024 to May 2024
Nuvve (NASDAQ:NVVE)
Historical Stock Chart
From May 2023 to May 2024